Simon Lü
Director/Board Member at BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.
Profile
Da Zhong Lü is on the board of BrightGene Bio-Medical Technology Co., Ltd., SDIC Innovation Investment Management Co. Ltd., Dizal (Jiangsu) Pharmaceutical Co., Ltd.
and Dizal Pharma.
Dr. Lü received an MBA from McGill University and a doctorate and an undergraduate degree from Nankai University.
Simon Lü active positions
Companies | Position | Start |
---|---|---|
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Director/Board Member | 2017-05-12 |
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Director/Board Member | 2017-09-30 |
SDIC Innovation Investment Management Co. Ltd.
SDIC Innovation Investment Management Co. Ltd. Investment ManagersFinance SDIC Innovation Investment Management Co. Ltd. is a company headquartered in Beijing, China. The firm acts as an alternative investment manager. It was founded in 2009. | Director/Board Member | - |
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Director/Board Member | - |
Training of Simon Lü
McGill University | Masters Business Admin |
Nankai University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Commercial Services |
Private companies | 2 |
---|---|
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Health Technology |
SDIC Innovation Investment Management Co. Ltd.
SDIC Innovation Investment Management Co. Ltd. Investment ManagersFinance SDIC Innovation Investment Management Co. Ltd. is a company headquartered in Beijing, China. The firm acts as an alternative investment manager. It was founded in 2009. | Finance |